Showing results 1 to 3 of 3
| Title | Author(s) | Issue Date | |
|---|---|---|---|
CDK4/6 inhibitor plus endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: The new standard of care Journal:Asia-Pacific Journal of Clinical Oncology | 2021 | ||
Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring - The TADE study Journal:Clinical Cancer Research | 2016 | ||
| 2020 |